Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis

Nonalcoholic steatohepatitis (NASH) is the most severe and progressive form of nonalcoholic fatty liver disease (NAFLD), which can lead to life-threatening conditions, however, there is still no approved drug for the treatment of NASH. In this study we used human-like NASH mouse model and treated or...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Ganbold, Munkhzul, Owada, Yohei, Ozawa, Yusuke, Shimamoto, Yasuhiro, Ferdousi, Farhana, Tominaga, Kenichi, Zheng, Yun-Wen, Ohkohchi, Nobuhiro, Isoda, Hiroko
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6838085/
https://ncbi.nlm.nih.gov/pubmed/31700054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-52736-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky